Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hanan Fathy

Upregulation of Human Β-Defensin-3 and Cathelicidin LL-37 in Kaposi’s Sarcoma

F1000Research

English

Related publications

Transformation of Human Cathelicidin LL-37 Into Selective, Stable, and Potent Antimicrobial Compounds

English

Human Cathelicidin, LL-37, Inhibits Respiratory Syncytial Virus Infection in Polarized Airway Epithelial Cells

English

Modulation of Exogenous Antibiotic Activity by Host Cathelicidin LL-37

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

English

The RLR/NLR Expression and Pro-Inflammatory Activity of Tissue Mast Cells Are Regulated by Cathelicidin LL-37 and Defensin hBD-2

Scientific Reports

Multidisciplinary

2018

English

Isolated Gastric Kaposi’s Sarcoma

Annals of Gastroenterology

2019

English

Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement With Hydrophobic and Cationic Amino Acid Residues

Clinical and Vaccine Immunology

Medicine

Immunology

Allergy

Clinical Biochemistry

Microbiology

2002

English

Early Type I Interferon Response Induces Upregulation of Human Β-Defensin 1 During Acute HIV-1 Infection

PLoS ONE

Multidisciplinary

2017

English

Human Cathelicidin LL-37 Resistance and Increased Daptomycin MIC in Methicillin-Resistant Staphylococcus Aureus Strain USA600 (ST45) Are Associated With Increased Mortality in a Hospital Setting

Journal of Clinical Microbiology

Microbiology

2014

English

Human Beta-Defensin 3: A Novel Inhibitor of Staphylococcus-Produced Biofilm Production. Commentary on “Human Β-Defensin 3 Inhibits Antibiotic-Resistant Staphylococcus Biofilm Formation”

Journal of Surgical Research

Surgery

2014

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hanan Fathy

Upregulation of Human Β-Defensin-3 and Cathelicidin LL-37 in Kaposi’s Sarcoma

Related publications

Transformation of Human Cathelicidin LL-37 Into Selective, Stable, and Potent Antimicrobial Compounds

Human Cathelicidin, LL-37, Inhibits Respiratory Syncytial Virus Infection in Polarized Airway Epithelial Cells

Modulation of Exogenous Antibiotic Activity by Host Cathelicidin LL-37

The RLR/NLR Expression and Pro-Inflammatory Activity of Tissue Mast Cells Are Regulated by Cathelicidin LL-37 and Defensin hBD-2

Isolated Gastric Kaposi’s Sarcoma

Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement With Hydrophobic and Cationic Amino Acid Residues

Early Type I Interferon Response Induces Upregulation of Human Β-Defensin 1 During Acute HIV-1 Infection

Human Cathelicidin LL-37 Resistance and Increased Daptomycin MIC in Methicillin-Resistant Staphylococcus Aureus Strain USA600 (ST45) Are Associated With Increased Mortality in a Hospital Setting

Human Beta-Defensin 3: A Novel Inhibitor of Staphylococcus-Produced Biofilm Production. Commentary on “Human Β-Defensin 3 Inhibits Antibiotic-Resistant Staphylococcus Biofilm Formation”